Soleno Therapeutics Inc. (SLNO) shares entered oversold territory on Wednesday, with its Relative Strength Index (RSI) falling to 28.8 after trading as low as $37.23. This technical indicator, significantly below the S&P 500's RSI of 67.8, suggests to some investors that recent selling pressure may be exhausting, potentially signaling an attractive entry point for the stock, which has a 52-week range of $3.69 to $53.82.
Shares of Soleno Therapeutics (SLNO) have entered a technically oversold condition, as indicated by a Relative Strength Index (RSI) reading of 28.8. This occurred as the stock traded down to a low of $37.23, with its last trade at $37.30. The oversold status is specific to SLNO, as the broader market, represented by the S&P 500 ETF (SPY), exhibits a much stronger RSI of 67.8. From a technical perspective, an RSI below 30 suggests that the recent significant selling pressure may be nearing exhaustion. While the stock's current price is substantially above its 52-week low of $3.69, it represents a notable pullback from its 52-week high of $53.82, indicating a correction following a period of strong performance.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
